Tokyo, Japan

Yuko Nonaka

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Nonaka. Retrieved from https://idiyas.com/inventor/yuko-nonaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Nonaka: Innovator in Pharmaceutical Composition

Introduction

Yuko Nonaka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for nasal administration.

Latest Patents

Yuko Nonaka holds a patent for a pharmaceutical composition designed for administration to the nasal mucosa. This invention focuses on providing a nose drop that allows for high absorption of the peptide hormone oxytocin, or its acid addition salts and derivatives, through the nasal mucosa. The formulation is characterized by having an osmotic pressure ratio of less than 1, ensuring both efficacy and safety for users.

Career Highlights

Yuko Nonaka is associated with Teijin Pharma Limited, where she has been instrumental in advancing pharmaceutical research and development. Her work has been recognized for its potential to improve therapeutic outcomes for patients requiring oxytocin administration.

Collaborations

Yuko collaborates with notable colleagues, including Ryo Furukawa and Atsuhiro Nagano, who contribute to her innovative projects and research initiatives.

Conclusion

Yuko Nonaka's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in drug delivery systems, particularly in the area of nasal administration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…